BioLaurus Inc.

BioLaurus is a preclinical contract research organization serving the drug discovery and medical device industries. We offer preclinical research services based upon BioLaurus Preclin Platform®; an integrated and multi-modality imaging platform to accelerate drug discovery and development. BioLaurus capabilities include uCT, SPECT, PET, ultrasound, and optical imaging in support of small molecule and biologic biodistribution , and efficacy studies, as well as imaging toxicology services, iTOX™, including advanced in vivo ultrasound cardiac strain analysis. BioLaurus is a leader in contract imaging and quantitation for spinal devise product development.